AP BIOSCIENCES, INC.

Ajouter à une liste

Autres langues AP Biosciences, Inc.

Actions

6945

TW0006945009

Recherche biotechnologique et médicale

Cours en clôture Taipei Exchange 23/09/2026			Varia. 5j.	Varia. 1 janv.
137,00 ^TWD	+1,48%		+25,11%	-23,89%

12/08	AP Biosciences, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
15/05	AP Biosciences, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

12/08	AP Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
15/05	AP Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
12/05	Delos Capital and AP Biosciences Inc. Launch Collaboration to Create New Biotech Companies Focused on Next-Generation Antibodies
31/03	AP Biosciences, Inc. has filed an IPO in the amount of TWD 1.2562 billion.
23/03	AP Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
22/12	AP Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
12/08/25	AP Biosciences, Inc. Reports Earnings Results for the Half Year Ended June 30, 2025
24/07/25	Designing antibodies to think before they bind
14/05/25	AP Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
29/04/25	AP Biosciences Presents Preclinical Data on P95her/Cd137 T-Cell Engager At American Association of Cancer Research Annual Meeting
22/04/25	AP Biosciences Doses First Patient In Phase 1/2 Clinical Trials Of AP402 For HER2+ Cancer Patients
22/04/25	AP Biosciences Doses First Patient in Phase 1/2 Clinical Trials of AP402 for HER2+ Cancer Patients
21/04/25	AP Biosciences to Present New Preclinical Data at American Association of Cancer Research Annual Meeting
13/08/24	AP Biosciences Inc Reports Earnings Results for the Half Year Ended June 30, 2024
19/03/24	AP Biosciences Inc Reports Earnings Results for the Full Year Ended December 31, 2023
10/08/23	AP Biosciences Inc Reports Earnings Results for the Half Year Ended June 30, 2023

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

-40% : Prolongation exceptionnelle ➤➤➤➤

PROFITEZ-EN MAINTENANT